Ipratropium bromide Gene Set

Dataset	DrugBank Drug Targets
Category	physical interactions
Type	drug
Description	The anhydrous form of the bromide salt of ipratropium. An anticholinergic drug, ipratropium bromide blocks the muscarinic cholinergic receptors in the smooth muscles of the bronchi in the lungs. This opens the bronchi, so providing relief in chronic obstructive pulmonary disease and acute asthma. (Chemical Entities of Biological Interest Ontology, CHEBI_46659)
External Link	http://www.drugbank.ca/drugs/DB00332
Similar Terms
Downloads & Tools

Genes

7 interacting proteins for the Ipratropium bromide drug from the curated DrugBank Drug Targets dataset.

Symbol	Name
CHRM1	cholinergic receptor, muscarinic 1
CHRM2	cholinergic receptor, muscarinic 2
CHRM3	cholinergic receptor, muscarinic 3
CYP2D6	cytochrome P450, family 2, subfamily D, polypeptide 6
CYP3A4	cytochrome P450, family 3, subfamily A, polypeptide 4
SLC22A4	solute carrier family 22 (organic cation/zwitterion transporter), member 4
SLC22A5	solute carrier family 22 (organic cation/carnitine transporter), member 5